Specific absorbed fractions of energy from internal photon sources in brain tumor and cerebrospinal fluid.
Transferrin, when injected intracranially into glioblastoma multiforme lesions, acts as a cytotoxic substance. Transferrin, radiolabeled with In-111, can be coinjected and subsequent scintigraphic imaging can demonstrate the biokinetics of the cytotoxic transferrin. The administration of 111In transferrin into a brain tumor results in distribution of radioactivity in the brain, brain tumor, and the cerebrospinal fluid (CSF). Information about absorbed radiation doses to these regions, as well as other nearby tissues and organs, is important for evaluating radiation-related risks from this procedure. The radiation dose is usually estimated for a mathematical representation of the human body. We have included source/target regions for the eye, lens of the eye, spinal column, spinal CSF, cranial CSF, and a 100-g tumor within the brain of an adult male phantom developed by Cristy and Eckerman. The mathematical models of the spinal column, spinal CSF, and the eyes were developed previously, however, these source/targets have not been routinely included in photon transport simulations. Specific absorbed fractions (SAFs) as a function of photon energy were calculated using the ALGAMP computer code, which utilizes Monte Carlo techniques for simulating photon transport. The ALGAMP code was run three times, with the source activity distributed uniformly within the tumor, cranial CSF, and the spinal CSF volumes. These SAFs, which were generated for 12 discrete photon energies ranging from 0.01 to 4.0 MeV, were used with decay scheme data to calculate S-values needed for estimating absorbed doses. S-values for 111In are given for three source regions (brain tumor, cranial CSF, and spinal CSF) and all standard target regions/organs, the eye and lens, as well as to tissues within these source regions. S-values for the skeletal regions containing active marrow are estimated. These results are useful in evaluating the radiation doses from intracranial administration of 111In transferrin. The SAFs are also generally useful for calculation of absorbed dose from any radionuclide in these source regions.
Evans
J F
JF
Nuclear Engineering Program, Ohio State University, Columbus, USA.
Stabin
M G
MG
Stubbs
J B
JB
D000328:Adult; D055592:Biophysical Phenomena; D001703:Biophysics; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000532:radiotherapy*; D005909:Glioblastoma / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000532:radiotherapy; D006801:Humans; D007205:Indium Radioisotopes / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008961:Models, Structural; D009010:Monte Carlo Method; D017785:Photons; D011880:Radiotherapy Planning, Computer-Assisted; D014018:Tissue Distribution; D014168:Transferrin / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics
D007205:Indium Radioisotopes; D014168:Transferrin